Medidata Solutions Inc (MDSO) : Polar Capital Llp scooped up 120,621 additional shares in Medidata Solutions Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 15, 2016. The investment management firm now holds a total of 709,386 shares of Medidata Solutions Inc which is valued at $38,647,349.Medidata Solutions Inc makes up approximately 0.71% of Polar Capital Llp’s portfolio.
Other Hedge Funds, Including , Capital Guardian Trust Co added MDSO to its portfolio by purchasing 111 company shares during the most recent quarter which is valued at $6,047.Teachers Advisors Inc boosted its stake in MDSO in the latest quarter, The investment management firm added 6,203 additional shares and now holds a total of 97,572 shares of Medidata Solutions Inc which is valued at $5,315,723. Medidata Solutions Inc makes up approx 0.01% of Teachers Advisors Inc’s portfolio.Cable Hill Partners reduced its stake in MDSO by selling 135 shares or 48.39% in the most recent quarter. The Hedge Fund company now holds 144 shares of MDSO which is valued at $7,806. Medidata Solutions Inc makes up approx 0.01% of Cable Hill Partners’s portfolio.
Medidata Solutions Inc closed down -0.37 points or -0.68% at $53.73 with 3,12,342 shares getting traded on Thursday. Post opening the session at $54.01, the shares hit an intraday low of $53.08 and an intraday high of $54.38 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.
On the company’s financial health, Medidata Solutions Inc reported $0.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Jul 20, 2016. Analyst had a consensus of $0.23. The company had revenue of $114.60 million for the quarter, compared to analysts expectations of $112.38 million. The company’s revenue was up 16.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.22 EPS.
Many Wall Street Analysts have commented on Medidata Solutions Inc. Medidata Solutions Inc was Downgraded by Wells Fargo to ” Market Perform” on Jul 21, 2016. Needham Resumed Medidata Solutions Inc on Jul 11, 2016 to “Buy”, Price Target of the shares are set at $55.
Medidata Solutions Inc. (Medidata) provides cloud-based solutions for life sciences. The Company’s solutions are Medidata Rave an electronic data capture (EDC) and clinical data management system (CDMS) solution; Medidata CTMS a clinical trial management solution; Medidata Designer a protocol design tool; Medidata Insights which offer clinical business analytics and metrics; Medidata Balance a randomization and trial supply management solution; Medidata Patient Cloud an electronic patient-reported outcome (ePRO) application; Medidata Grants Manager which develops and manages trial budgets; Medidata contract research organizations (CRO) Contractor an analytics tool; Medidata SQM a set of cloud-based site quality management dashboards; Medidata Coder a medical coding and synonym management solution; Medidata Safety Gateway which collects and transmits events and related data from the EDC system and Medidata Targeted SDV which implements risk-based monitoring strategies.